SEC Form 4 · accession 0001104659-18-004810
MARINUS PHARMACEUTICALS INC · MRNS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward F Smith
Officer — CFO
Period of report
Jan 29, 2018
Accepted (ET)
Jan 29, 2018 · 8:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jan 29, 2018 | S | 3,000 | $7.91 | D | 49,800 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the sale of common stock in order to satisfy tax withholding obligations upon vesting of restricted stock.